Prescription Drugs

Prescription Drug Materials

• KFF Health News: Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs

  May 18, 2026: President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs, as the agencies he oversees undertook an agenda that largely benefited the company. On May 1 Read More >

• Retirees Praise Supreme Court Decision Upholding Medicare Drug Price Negotiation Law; Urges Congress to Expand Number of Drugs Eligible for the Program to Lower Costs for Seniors

  May 18, 2026: Statement from Richard Fiesta, Executive Director of the Alliance for Retired Americans regarding the U.S. Supreme Court’s rejection of appeals by drug corporations seeking to overturn the Medicare drug price negotiation program Read More >

• Medical Journal Confirms that Medicare’s Annual Cap on Out of Pocket Drug Costs is Keeping Seniors on their Medications

  May 15, 2026: New research shows that the Inflation Reduction Act’s provision capping yearly prescription drug costs has helped Medicare patients afford and stay on their prescription medications. The annual out-of-pocket drug costs cap is $2 Read More >

• KFF Health News: Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.

  May 15, 2026: Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry. No surprise. About 60% of American adults are “w Read More >

• Retirees Welcome Second Round of Lower-Priced Drugs Negotiated Under the Inflation Reduction Act

  November 25, 2025: The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding the Administration's announcement of lower, negotiated prices for people with Medicare: “The requiremen Read More >

• HHS Secretary Grilled About Medicaid, CDC Firings, and Vaccines During Contentious Hearing

  September 05, 2025: During a tense hearing on Thursday, members of the Senate Finance Committee pressed HHS Secretary Robert F. Kennedy Jr. about his position on a number of issues, including Medicare drug price negotiation, vaccine skepticism, recen Read More >

• Study Debunks Pharmaceutical Industry’s Claims That Medicare Drug Price Negotiation Would Harm R&D

  July 18, 2025: A new study by Bentley University debunks the pharmaceutical industry’s claims that the Medicare drug price negotiation law would harm innovation and research. Drug research and development (R&D) spending actually increased Read More >

• Senate Votes to Harm Older Americans’ Health and Financial Security to Reward Billionaires With Massive Tax Cuts

  July 01, 2025: Deep Cuts to Medicaid and SNAP Will Put Most Vulnerable Seniors at Risk The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding the Senate Budget Resolution: � Read More >

• New Fact Sheet: Threats to Retirees in House Budget Package

  May 30, 2025: This week, the Alliance released a new fact sheet detailing how the Republican budget, recently passed in the House of Representatives, will be harmful for seniors. The One Big Beautiful Bill Act (H.R. 1) will slash $490 billio Read More >

• Drug Industry Quietly Funds “Patient Advocacy” Groups to Fight Medicare Drug Price Negotiations

  May 23, 2025: A new investigation by Patients for Affordable Drugs (P4AD) has uncovered a troubling tactic used by the pharmaceutical industry to protect profits and keep drug prices high: secretly funding so-called “patient advocacy” group Read More >